Vertex Pharmaceuticals (VRTX) Change in Intangibles (2014 - 2024)
Vertex Pharmaceuticals' quarterly Change in Intangibles came in at $375.4 million in Q4 2024, up 547.24% year-on-year from $58.0 million in Q1 2024, and up 4975.32% quarter-over-quarter from -$7.7 million in Q2 2024.
Vertex Pharmaceuticals has reported Change in Intangibles for 3 years, with the latest figure at $375.4 million in Q4 2024.
- For the quarter ending Q4 2024, Change in Intangibles rose 547.24% year-over-year to $375.4 million; the trailing twelve-month figure through Sep 2025 stood at $375.4 million (up 389.44% YoY), and the FY2024 full-year result was $187.7 million, up 223.62% from the prior year.
- Change in Intangibles for Q4 2024 stood at $375.4 million, up from -$7.7 million in the prior quarter.
- The five-year high for Change in Intangibles was $375.4 million in Q4 2024, with the low at -$180.0 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 375.40 Mn |
| Dec 31, 2024 | 375.40 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -180.00 Mn |
| Mar 31, 2024 | -180.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Dec 31, 2014 | 10.00 Mn |
| Dec 31, 2014 | 10.00 Mn |